Julie Papanek Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 14,760 shares at $21.55 ($320K) on 2022-12-02, disclosed to the SEC on 2022-12-05.
Open-market sale of $320k DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.72 | 4,760 | $103K | 32.3% |
| 2 | $21.72 | 4,760 | $103K | 32.3% |
| 3 | $22.34 | 240 | $5K | 1.7% |
| 4 | $21.55 | 5,000 | $108K | 33.7% |
| Total | $21.67 avg | 14,760 | $320K | 100% |
| Filing → |
| DAWN | SELL | 2023-01-04 | $1.0M | — | Filing → |
| DAWN | SELL | 2022-12-12 | $192K | — | Filing → |
| DAWN | SELL | 2022-11-03 | $300K | — | Filing → |